Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasmsAlicia Arenas Cortés, Joaquín Martínez‐López, María Luz Morales et al.|Haematologica|2018Cited by 9
High Throughput Screening, With a Flow Cytometry Automated Platform (Ex vivo Biotech), To Identify Potential Combination Partners, For The JAK 2 Inhibitor RuxolitinibAlicia Arenas, Joaquín Martínez‐López, Pilar Hernández-Campo et al.|Blood|2013Cited by 2
Ruxolitinib in Combination with Nilotinib and Prednisolone, a New Synergistic Approach to Treat MyelofibrosisAlicia Arenas, Joaquín Martínez‐López, Joan Ballesteros et al.|Blood|2014Cited by 1